Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 28

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Is there a role for antibiotics in the treatment of chronic rhinosinusitis?

Smith, Stephanie Shintani, Kim, Raymond, Douglas, Richard · 2022 · Journal of Allergy and Clinical Immunology

Abstract

Rhinosinusitis is one of the most common reasons for adult outpatient antibiotic prescriptions, though there is little clinical evidence to support this practice, especially for chronic rhinosinusitis. Despite considerable research, the etiology of chronic rhinosinusitis, including the pathogenic role of microbes, remains poorly understood. Rigorous studies of the efficacy of antibiotic treatment of chronic sinusitis are surprisingly few in number and the results are somewhat conflicting. This article will review the rationales for and against the treatment of chronic rhinosinusitis with antibiotics, based on current evidence and understanding of pathophysiology, and will also summarize the current guidelines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2022.02.004

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 122

  1. Smith, 2013, National burden of antibiotic use for adult rhinosinusitis, J Allergy Clin Immunol, 132, 1230, 10.1016/j.jaci.2013.07.009 · DOI
  2. Garbutt, 2012, Amoxicillin for acute rhinosinusitis: a randomized controlled trial, JAMA, 307, 685, 10.1001/jama.2012.138 · DOI
  3. Meltzer, 2005, Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo, J Allergy Clin Immunol, 116, 1289, 10.1016/j.jaci.2005.08.044 · DOI · Paper page
  4. Merenstein, 2005, Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial, J Fam Pract, 54, 144
  5. Lindbaek, 1998, Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT, Rhinology, 36, 7
  6. Stalman, 1997, The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial, Br J Gen Pract, 47, 794
  7. van Buchem, 1997, Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis, Lancet, 349, 683, 10.1016/S0140-6736(96)07585-X · DOI · Paper page
  8. Kenealy, 2013, Antibiotics for the common cold and acute purulent rhinitis, Cochrane Database Syst Rev, 10.1002/14651858.CD000247.pub3 · DOI · Paper page
  9. Young, 2008, Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data, Lancet, 371, 908, 10.1016/S0140-6736(08)60416-X · DOI · Paper page
  10. Lindbaek, 1996, Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults, BMJ, 313, 325, 10.1136/bmj.313.7053.325 · DOI
  11. Hadley, 2010, Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis, Laryngoscope, 120, 1057, 10.1002/lary.20878 · DOI
  12. Fokkens, 2020, European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology, 58, 1, 10.4193/Rhin20.401 · DOI · Paper page
  13. Rudmik, 2016, Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study, Int Forum Allergy Rhinol, 6, 557, 10.1002/alr.21769 · DOI
  14. Orlandi, 2021, International consensus statement on allergy and rhinology: rhinosinusitis 2021, Int Forum Allergy Rhinol, 11, 213, 10.1002/alr.22741 · DOI · Paper page
  15. Liu, 2020, Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis, Allergy Asthma Immunol Res, 12, 176, 10.4168/aair.2020.12.2.176 · DOI
  16. Peters, 2014, Diagnosis and management of rhinosinusitis: a practice parameter update, Ann Allergy Asthma Immunol, 113, 347, 10.1016/j.anai.2014.07.025 · DOI · Paper page
  17. Rosenfeld, 2015, Clinical practice guideline (update): adult sinusitis, Otolaryngol Head Neck Surg, 152, S1
  18. Hoggard, 2017, Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease, Clin Microbiol Rev, 30, 321, 10.1128/CMR.00060-16 · DOI
  19. Bhattacharyya, 2005, Bacterial infection in chronic rhinosinusitis: a controlled paired analysis, Am J Rhinol, 19, 544, 10.1177/194589240501900602 · DOI
  20. Wood, 2012, Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune response, Am J Rhinol Allergy, 26, 265, 10.2500/ajra.2012.26.3779 · DOI
  21. Kim, 2013, The interaction between bacteria and mucosal immunity in chronic rhinosinusitis: a prospective cross-sectional analysis, Am J Rhinol Allergy, 27, 183, 10.2500/ajra.2013.27.3974 · DOI
  22. Verderosa, 2019, Bacterial biofilm eradication agents: a current review, Front Chem, 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
  23. Vickery, 2019, The role of Staphylococcus aureus in patients with chronic sinusitis and nasal polyposis, Curr Allergy Asthma Rep, 19, 21, 10.1007/s11882-019-0853-7 · DOI
  24. Stewart, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
  25. Kern, 2008, Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis, Am J Rhinol, 22, 549, 10.2500/ajr.2008.22.3228 · DOI · Paper page
  26. Bachert, 2001, Total and specific IgE in nasal polyps is related to local eosinophilic inflammation, J Allergy Clin Immunol, 107, 607, 10.1067/mai.2001.112374 · DOI · Paper page
  27. Van Zele, 2004, Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis, J Allergy Clin Immunol, 114, 981, 10.1016/j.jaci.2004.07.013 · DOI · Paper page
  28. Bachert, 2010, Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma, J Allergy Clin Immunol, 126, 962, 10.1016/j.jaci.2010.07.007 · DOI · Paper page
  29. Feazel, 2012, Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis, Laryngoscope, 122, 467, 10.1002/lary.22398 · DOI · Paper page
  30. Hugenholtz, 2002, Exploring prokaryotic diversity in the genomic era, Genome Biol, 3, 10.1186/gb-2002-3-2-reviews0003 · DOI
  31. Biswas, 2015, The nasal microbiota in health and disease: variation within and between subjects, Front Microbiol, 9, 134, 10.3389/fmicb.2015.00134 · DOI · Paper page
  32. Hauser, 2015, Sinus culture poorly predicts resident microbiota, Int Forum Allergy Rhinol, 5, 3, 10.1002/alr.21428 · DOI
  33. Ramakrishnan, 2015, Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome, J Allergy Clin Immunol, 136, 334, 10.1016/j.jaci.2015.02.008 · DOI · Paper page
  34. Bassiouni, 2015, Sinonasal microbiome sampling: a comparison of techniques, PLoS One, 10, 10.1371/journal.pone.0123216 · DOI
  35. Gevaert, 2013, Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma, J Allergy Clin Immunol, 131, 110, 10.1016/j.jaci.2012.07.047 · DOI · Paper page
  36. Stevens, 2017, Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 5, 1061, 10.1016/j.jaip.2016.12.027 · DOI · Paper page
  37. Stevens, 2019, Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis, J Allergy Clin Immunol Pract, 7, 2812, 10.1016/j.jaip.2019.05.009 · DOI · Paper page
  38. Tan, 2017, Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois, J Allergy Clin Immunol, 139, 699, 10.1016/j.jaci.2016.06.063 · doi:10.1016/j.jaci.2016.06.063
  39. Soler, 2013, Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations, Int Forum Allergy Rhinol, 3, 31, 10.1002/alr.21064 · DOI
  40. Tomassen, 2016, Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers, J Allergy Clin Immunol, 137, 1449, 10.1016/j.jaci.2015.12.1324 · DOI · Paper page
  41. Wang, 2016, Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania, J Allergy Clin Immunol, 138, 1344, 10.1016/j.jaci.2016.05.041 · DOI · Paper page
  42. Ryu, 2021, A survey on the management of chronic rhinosinusitis in the Korean Rhinologic Society, J Rhinol, 28, 44, 10.18787/jr.2020.00343 · DOI
  43. Lee, 2011, Regional and specialty variations in the treatment of chronic rhinosinusitis, Laryngoscope, 121, 1092, 10.1002/lary.21550 · doi:10.1002/lary.21550
  44. Fang, 2018, Antibiotic use patterns in endoscopic sinus surgery: a survey of the American Rhinologic Society membership, Int Forum Allergy Rhinol, 8, 522, 10.1002/alr.22085 · doi:10.1002/alr.22085
  45. Namyslowski, 2002, Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults, J Chemother, 14, 508, 10.1179/joc.2002.14.5.508 · DOI
  46. Legent, 1994, A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis, Chemotherapy, 40, 8, 10.1159/000239310 · DOI
  47. Hansen, 2019, Adverse events in people taking macrolide antibiotics versus placebo for any indication, Cochrane Database Syst Rev, 1
  48. Sadarangani, 2015, Non-anti-infective effects of antimicrobials and their clinical applications: a review, Mayo Clin Proc, 90, 109, 10.1016/j.mayocp.2014.09.006 · DOI
  49. Shimizu, 2016, Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan, Auris Nasus Larynx, 43, 131, 10.1016/j.anl.2015.08.014 · DOI
  50. Lechien, 2019, A 10-year follow-up of a randomized prospective study of 2 treatments for chronic rhinosinusitis without nasal polyps and investigation of the impact of gastroeosophageal reflux disease in the resistance to treatment, Ear Nose Throat J
  51. Lasso, 2017, Long-term low-dose macrolides for chronic rhinosinusitis in adults—a systematic review of the literature, Clin Otolaryngol, 42, 637, 10.1111/coa.12787 · DOI
  52. Spagnolo, 2013, Long-term macrolide treatment for chronic respiratory disease, Eur Respir J, 42, 239, 10.1183/09031936.00136712 · DOI
  53. Shimizu, 2003, In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells, Am J Respir Crit Care Med, 168, 581, 10.1164/rccm.200212-1437OC · DOI · Paper page
  54. Tamaoki, 1992, Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro, J Antimicrob Chemother, 29, 173, 10.1093/jac/29.2.173 · doi:10.1093/jac/29.2.173
  55. Takizawa, 1997, Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells, Am J Respir Crit Care Med, 156, 266, 10.1164/ajrccm.156.1.9612065 · DOI · Paper page
  56. Tateda, 2001, Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 45, 1930, 10.1128/AAC.45.6.1930-1933.2001 · DOI
  57. Yanagihara, 2002, Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model, J Antimicrob Chemother, 49, 867, 10.1093/jac/dkf013 · DOI
  58. Ehnhage, 2008, Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis, Int J Antimicrob Agents, 31, 561, 10.1016/j.ijantimicag.2008.01.027 · doi:10.1016/j.ijantimicag.2008.01.027
  59. Margaritis, 2007, Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis, Am J Rhinol, 21, 574, 10.2500/ajr.2007.21.3071 · doi:10.2500/ajr.2007.21.3071
  60. Fang, 2009, Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis, Int J Antimicrob Agents, 34, 67, 10.1016/j.ijantimicag.2009.01.014 · doi:10.1016/j.ijantimicag.2009.01.014
  61. Siu, 2020, Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trial, Xenobiotica, 50, 1443, 10.1080/00498254.2020.1814973 · DOI · Paper page
  62. Sabino, 2017, Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial, Int Forum Allergy Rhinol, 7, 135, 10.1002/alr.21846 · doi:10.1002/alr.21846
  63. Huck, 1993, Cefaclor vs amoxicillin in the treatment of acute, recurrent, and chronic sinusitis, Arch Fam Med, 2, 497, 10.1001/archfami.2.5.497 · DOI
  64. Amini, 2009, A comparing study of clarithromycin XL with co-amoxiclav for treatment of chronic sinusitis: a clinical trial, Iran J Clinic Infect Dis, 4, 197
  65. Fan, 2014, High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis, J Laryngol Otol, 128, 236, 10.1017/S0022215114000279 · DOI
  66. Jareoncharsri, 2004, An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients, Rhinology, 42, 23
  67. Namysłowski, 1998, Randomized clinical trial comparing the efficacy and safety of Augmentin versus cefuroxime in the treatment of chronic sinusitis in adult patients, Med Sci Monit, 4, PI551
  68. Head, 2016, Systemic and topical antibiotics for chronic rhinosinusitis, Cochrane Database Syst Rev, 4
  69. Wallwork, 2006, A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis, Laryngoscope, 116, 189, 10.1097/01.mlg.0000191560.53555.08 · DOI · Paper page
  70. Videler, 2011, Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial, Allergy, 66, 1457, 10.1111/j.1398-9995.2011.02693.x · DOI · Paper page
  71. Oakley, 2017, The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP), Curr Allergy Asthma Rep, 17, 30, 10.1007/s11882-017-0696-z · DOI
  72. Dubin, 2007, Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics, Ann Allergy Asthma Immunol, 98, 32, 10.1016/S1081-1206(10)60856-3 · DOI
  73. Sreenath, 2015, A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of “maximal medical therapy” for chronic rhinosinusitis, Int Forum Allergy Rhinol, 5, 820, 10.1002/alr.21542 · DOI
  74. Pinto Bezerra Soter, 2017, Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps, Rhinology, 55, 175, 10.4193/Rhino15.291 · DOI
  75. Lemiengre, 2012, Antibiotics for clinically diagnosed acute rhinosinusitis in adults, Cochrane Database Syst Rev, 10
  76. Ahovuo-Saloranta, 2014, Antibiotics for acute maxillary sinusitis in adults, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD000243.pub3 · DOI
  77. Sharp, 2007, Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002, Arch Otolaryngol Head Neck Surg, 133, 260, 10.1001/archotol.133.3.260 · DOI
  78. Kaszuba, 2006, Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists, Am J Rhinol, 20, 186, 10.1177/194589240602000214 · DOI
  79. Dubin, 2007, American Rhinologic Society member survey on “maximal medical therapy” for chronic rhinosinusitis, Am J Rhinol, 21, 483, 10.2500/ajr.2007.21.3047 · DOI
  80. Lund, 2005, Maximal medical therapy for chronic rhinosinusitis, Otolaryngol Clin N Am, 38, 1301, 10.1016/j.otc.2005.07.003 · doi:10.1016/j.otc.2005.07.003
  81. Fokkens, 2007, European position paper on rhinosinusitis and nasal polyps 2007, Rhinology Supplement, 20, 1
  82. Fokkens, 2012, European Position Paper on Rhinosinusitis and Nasal Polyps 2012, Rhinol Suppl, 23, 3
  83. Berkhout, 2013, Importance of bacteriology in upper airways of patients with cystic fibrosis, J Cyst Fibros, 12, 525, 10.1016/j.jcf.2013.01.002 · DOI
  84. Oomen, 2012, Sinonasal manifestations in cystic fibrosis, Int J Otolaryngol, 2012, 10.1155/2012/789572 · DOI
  85. Johansen, 2012, Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response, J Cyst Fibros, 11, 525, 10.1016/j.jcf.2012.04.011 · DOI
  86. Lim, 2014, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis, J Clin Microbiol, 52, 425, 10.1128/JCM.02204-13 · DOI
  87. Price, 2013, Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation, Microbiome, 1, 27, 10.1186/2049-2618-1-27 · DOI · Paper page
  88. Briaud, 2019, Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells, Sci Rep, 9, 16564, 10.1038/s41598-019-52975-z · DOI
  89. Bonestroo, 2010, Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways, J Cyst Fibros, 9, 130, 10.1016/j.jcf.2010.01.001 · DOI
  90. Mainz, 2009, Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis, Thorax, 64, 535, 10.1136/thx.2008.104711 · DOI · Paper page
  91. Psaltis, 2007, Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis, Laryngoscope, 117, 1302, 10.1097/MLG.0b013e31806009b0 · DOI · Paper page
  92. Clement, 2005, Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis, J Infect Dis, 192, 1023, 10.1086/432735 · DOI · Paper page
  93. Kim, 2015, Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity, Int Forum Allergy Rhinol, 5, 380, 10.1002/alr.21431 · doi:10.1002/alr.21431
  94. Bacci, 2020, Taxonomic variability over functional stability in the microbiome of cystic fibrosis patients chronically infected by Pseudomonas aeruginosa, bioRxiv
  95. Whelan, 2017, Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis, PLoS One, 12, 10.1371/journal.pone.0172811 · DOI
  96. Wagner Mackenzie, 2021, Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study, Respir Res, 22, 106, 10.1186/s12931-021-01697-w · DOI
  97. Karanth, 2019, Medical interventions for chronic rhinosinusitis in cystic fibrosis, Cochrane Database Syst Rev, 10
  98. Mainz, 2014, Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study, Drug Des Devel Ther, 8, 209, 10.2147/DDDT.S54064 · DOI
  99. Harvey, 2009, Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis, Immunol Allergy Clin North Am, 29, 689, 10.1016/j.iac.2009.07.006 · DOI
  100. Cervin, 2005, Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis, Otolaryngol Clin North Am, 38, 1339, 10.1016/j.otc.2005.08.002 · DOI
  101. Jaffe, 1998, Long-term azithromycin may improve lung function in children with cystic fibrosis, Lancet, 351, 420, 10.1016/S0140-6736(05)78360-4 · DOI · Paper page
  102. Cho, 2019, Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa, Am J Rhinol Allergy, 33, 129, 10.1177/1945892418815615 · DOI
  103. Comegna, 2021, Elexacaftor-tezacaftor-ivacaftor therapy for cystic dibrosis patients with the F508del/unknown genotype, Antibiotics (Basel), 10, 828, 10.3390/antibiotics10070828 · DOI
  104. Shah, 2018, Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review, Int Forum Allergy Rhinol, 8, 729, 10.1002/alr.22082 · DOI
  105. Harvey, 2008, Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation, Otolaryngol Head Neck Surg, 139, 137, 10.1016/j.otohns.2008.04.020 · DOI · Paper page
  106. Goddard, 2017, Effects of endoscopic sinus surgery and device on irrigation, Otolaryngol Head Neck Surg, 139, P75
  107. Uren, 2008, Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis, Laryngoscope, 118, 1677, 10.1097/MLG.0b013e31817aec47 · doi:10.1097/mlg.0b013e31817aec47
  108. Jervis-Bardy, 2012, A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis, Laryngoscope, 122, 2148, 10.1002/lary.23486 · DOI
  109. Carr, 2016, Alteration in bacterial culture after treatment with topical mupirocin for recalcitrant chronic rhinosinusitis, JAMA Otolaryngol Head Neck Surg, 142, 138, 10.1001/jamaoto.2015.3059 · DOI
  110. Jervis-Bardy, 2012, Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery, Int Forum Allergy Rhinol, 2, 111, 10.1002/alr.20106 · DOI
  111. Kisiel, 2020, Development of bacterial resistance during treatment with topical gentamicin for chronic rhinosinusitis in patients with cystic fibrosis and primary ciliary dyskinesis. Retrospective case series, Otolaryngol Pol, 74, 33, 10.5604/01.3001.0013.7851 · doi:10.5604/01.3001.0013.7851
  112. Aanaes, 2021, Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery, Acta Otolaryngol, 141, 181, 10.1080/00016489.2020.1841909 · doi:10.1080/00016489.2020.1841909
  113. Cho, 2019, In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms, Int Forum Allergy Rhinol, 9, 486, 10.1002/alr.22285 · doi:10.1002/alr.22285
  114. Hill, 2000, The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions, J Hosp Infect, 45, 198, 10.1053/jhin.2000.0733 · DOI
  115. Jeronimo, 2020, Effects of povidone-iodine composite on the elimination of bacterial biofilm, Int Forum Allergy Rhinol, 10, 884, 10.1002/alr.22568 · doi:10.1002/alr.22568
  116. Daood, 2020, A quaternary ammonium silane antimicrobial triggers bacterial membrane and biofilm destruction, Sci Rep, 10, 10970, 10.1038/s41598-020-67616-z · DOI
  117. Gaurav, 2020, Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia, Int J Antimicrob Agents, 56, 10.1016/j.ijantimicag.2020.106022 · DOI
  118. Kamel, 2012, Preoperative skin antiseptic preparations for preventing surgical site infections: a systematic review, Infect Control Hosp Epidemiol, 33, 608, 10.1086/665723 · doi:10.1086/665723
  119. Jervis-Bardy, 2009, Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery, Am J Rhinol Allergy, 23, 549, 10.2500/ajra.2009.23.3366 · doi:10.2500/ajra.2009.23.3366
  120. Jiang, 2008, Postoperative antibiotic care after functional endoscopic sinus surgery, Am J Rhinol, 22, 608, 10.2500/ajr.2008.22.3241 · doi:10.2500/ajr.2008.22.3241
  121. Albu, 2010, Prophylactic antibiotics in endoscopic sinus surgery: a short follow-up study, Am J Rhinol Allergy, 24, 306, 10.2500/ajra.2010.24.3475 · doi:10.2500/ajra.2010.24.3475
  122. Zhang, 2014, Culture-inappropriate antibiotic therapy decreases quality of life improvement after sinus surgery, Int Forum Allergy Rhinol, 4, 403, 10.1002/alr.21277 · DOI

Cited by

See all 28

Metadata

Authors
Smith, S. S., Kim, R., & Douglas, R.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2022-05
Volume
149
Issue
5
Pages
1504-1512
ISSN
0091-6749
Cited by
28
References
7
Language
en
Licence
Funders
  • National Institute of Allergy and Infectious Diseases (U19 AI106683)
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is there a role for antibiotics in the treatment of chronic rhinosinusitis? https://app.cochat.ai/papers/10.1016/j.jaci.2022.02.004
The paper
Smith, S. S., Kim, R., & Douglas, R. (2022). Is there a role for antibiotics in the treatment of chronic rhinosinusitis? Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2022.02.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.